RWD Data Insights: Linkage of patient services and real-world healthcare data
Explore UBC’s study to see how linking patient support programs and RWD is a source of valuable insights into the patient healthcare journey.
Enriching clinical studies with longitudinal real-world data
Download our case study to explore how UBC linked clinical trial data with six years of pre- and post-trial patient healthcare data, for rich longitudinal real-world evidence development.
Understanding the Natural History of Disease
Learn more about the benefits of natural history studies in drug development.
Gain Strategic Insights by Linking Clinical Trial Data to Real World Data
Read our white paper to explore how integrating RWD/RWE with clinical trial data can overcome challenges and enhance regulatory submissions.
The FDA Expands the Types of Confirmatory Evidence Sources to Support Drug Effectiveness Studies
Learn how the inclusion of real-world data (RWD) and evidence from natural history studies can improve your integrated evidence strategy.
Improve Patient Diversity and Expand Access in a Real-World Setting
Boost enrollment in clinical studies that reflects the diversity of the population who will use the medical product.
Planning Real-World Studies to Support Cell and Gene Therapy Evidence Generation Needs
As the cell and gene therapy pipeline evolves, manufacturers are now faced with the need to provide long-term safety and efficacy data.
How to Start Your Real-World Evidence Journey
Figure out how to maximize product value with early, integrated RWE planning.
Optimizing Evidence Generation in Rare Disease Studies with Patient-Centric Strategies
RWD and RWE are emerging as strategic tools in rare disease study design to address research challenges with real-world solutions.
